18 March 2022
The Global Fund is seeking information on the readiness and use of SARS-CoV-2 antigen-detection rapid diagnostic tests for COVID-19 self-testing in countries implementing Global Fund-supported programs. We kindly request Country Coordinating Mechanisms and Principal Recipients to support completion of the online survey (EN | ES | FR | PT) by 31 March 2022 by forwarding the links to relevant in-country focal points.
On 9 March 2022, WHO released interim guidance on the use of SARS-CoV-2 antigen-detection rapid diagnostic tests for COVID-19 self-testing recommending SARS-CoV-2 Ag-RDTs self-testing to be offered in addition to professionally administered testing services. The guidance also covers implementation considerations to guide decisions on whether and how to adopt self-testing in different contexts, including the populations being prioritized, the disease prevalence in that population, and the impact on accessibility of testing, health care services and results reporting.